Drug & intervention
plerixafor
RxCUI 733003
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
5 shownTrial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...NCT05470491 · 2023-01-26
RECRUITINGStem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)NCT03182426 · 2017-08-15
COMPLETEDHIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV InfectionNCT02343666 · 2016-08-15
WITHDRAWNPlerixafor in Diabetic Wound HealingNCT02790957 · 2016-06-01
TERMINATEDScleroderma Treatment With Autologous Transplant (STAT) StudyNCT01413100 · 2011-09-15
COMPLETEDConditions being studied
Critical Limb Ischemia1Diabetes1Diabetes Mellitus, Type 11Hematologic Malignancies1HIV1Human Immunodeficiency Virus 1 Positive1Stage I Adult Hodgkin Lymphoma1Stage I Adult Non-Hodgkin Lymphoma1Stage II Adult Hodgkin Lymphoma1Stage II Adult Non-Hodgkin Lymphoma1Stage III Adult Hodgkin Lymphoma1Stage III Adult Non-Hodgkin Lymphoma1Stage IV Adult Hodgkin Lymphoma1Stage IV Adult Non-Hodgkin Lymphoma1Systemic Scleroderma1Wounds1
Research locations
SeattleWashington, United States2Ann ArborMichigan, United States1BethesdaMaryland, United States1BostonMassachusetts, United States1DenverColorado, United States1DuarteCalifornia, United States1DurhamNorth Carolina, United States1EdmontonAlberta, Canada1HoustonTexas, United States1Los AngelesCalifornia, United States1PadovaItaly1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.